Today: 25 January 2026
Subscribe
Browse Category

Stock Market Analysis News 24 September 2025 - 19 November 2025

Strive’s Bitcoin Bonanza: $1.3B Merger, 11K BTC and a Wild Stock Ride

ASST Stock Today: Strive Inc Slips as Hedge Fund Giant Adds Shares – What November 19, 2025 Really Means for Investors

Strive Inc. (NASDAQ: ASST) – the high-volatility Bitcoin treasury play co‑founded by Vivek Ramaswamy – spent Wednesday, November 19, 2025 giving back part of its recent rally even as a prominent hedge fund manager publicly increased his stake. Below is a full breakdown of today’s move, the fresh November 19 news, and how it fits into the bigger ASST story.…
19 November 2025
···
IonQ (INBX) Stock Soars on Quantum Breakthrough and $2B Deal – Bubble or Next Big Thing?

IonQ Q3 2025 Earnings (Nov. 5): Revenue Soars 222% to $39.9M, Full‑Year Outlook Raised; Here’s What It Means for IONQ Stock

Published: November 5, 2025 Summary: IonQ (NYSE: IONQ) reported $39.9 million in Q3 revenue—222% year over year and roughly 37% above the high end of its prior guidance—and lifted its full‑year 2025 sales outlook to $106–$110 million. Shares traded around the mid‑$50s after hours as investors parsed a sizable GAAP loss driven largely by non‑cash items. IonQ By the numbers…
5 November 2025
····
Kratos Defense (KTOS) Soars 300% on Drone Boom – Is the Rally Sustainable?

Kratos Defense (KTOS) Soars 300% on Drone Boom – Is the Rally Sustainable?

1. Company Background and Overview of Kratos Defense & Security Solutions, Inc. Kratos Defense & Security Solutions, Inc. is a U.S. technology company serving the defense and national security market. Founded in 1994 and headquartered in San Diego, Kratos specializes in mission-critical systems for military and government agencies Investing. The company operates through two main segments – Kratos Government Solutions…
5 November 2025
···
Recursion Pharmaceuticals (RXRX) – AI Drug Discovery Breakthroughs, CEO Shakeup & 2025 Stock Outlook

Recursion Pharmaceuticals (RXRX) – AI Drug Discovery Breakthroughs, CEO Shakeup & 2025 Stock Outlook

Below we dive into a detailed analysis of RXRX – covering the latest developments, the company’s AI-powered business model, financials, key partnerships, expert commentary, technical trends, forecasts, and how Recursion compares to other AI-focused biotech players. Latest Developments and News (Early November 2025) Q3 2025 Earnings & Milestone: Recursion’s third-quarter 2025 report (released Nov 5) was a mixed bag. The company…
5 November 2025
·
Energy Stock on Fire: EPD’s 7% Yield and Massive Growth Plans Might Be About to Spark a Rally

Energy Stock on Fire: EPD’s 7% Yield and Massive Growth Plans Might Be About to Spark a Rally

Recent News & Industry Context The past week’s headlines have been upbeat for midstream energy. On Oct 7, EPD announced its Q3 distribution of $0.545/unit (payable Nov 14, record Oct 31) Marketscreener – reinforcing a 27-year growth streak Financialcontent. Shortly after, a MarketBeat alert (Oct 25) noted that Weiss Ratings reaffirmed EPD at a “Buy” with an average $35.8 price target Marketbeat. Insider…
25 October 2025
···
Palantir’s Shocking Reinvention: From Secretive Spy Tech to $400B Cult Lifestyle Brand

Palantir’s 2025 Stock Surge: AI Goldmine or Overhyped Bubble?

Comprehensive Investment Analysis of Palantir Technologies Stock 2025 YTD Stock Performance: An AI-Fueled Surge (and Swings) Palantir’s stock has been on a remarkable tear in 2025. Year-to-date, PLTR shares have more than doubled (+130% as of early August) Businessinsider, following an astounding +340% gain in 2024 Businessinsider. This rally made Palantir the single best-performing stock in the S&P 500 for…
24 September 2025
····
1 2 3

Stock Market Today

  • Adobe Shares Dip Amid AI Competition Concerns, Stock Appears Undervalued
    January 25, 2026, 7:44 AM EST. Adobe's shares have fallen 30.8% over the past year, driven by concerns about increasing competition in artificial intelligence tools and digital media software. Despite a 14.9% decline in the last 30 days, Adobe's recent cash flow projections and discounted cash flow (DCF) model suggest the stock is trading 43.5% below intrinsic value at $301.07 per share. Analysts project free cash flow growing to $13.02 billion by 2030, indicating long-term strength in Creative and Document Cloud products. The price-to-earnings ratio (P/E) remains a key metric for evaluating Adobe alongside peers, reflecting market expectations for earnings growth amid evolving competitive pressures.
Go toTop